MORTON GROVE
GenericsMORTON GROVE is a generic drug manufacturer focused on Gastroenterology, Cardiovascular.
MORTON GROVE's Key Drugs
MORTON GROVE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
MORTON GROVE's Recent FDA Approvals
New NDA/BLA approvals for MORTON GROVE over the last two years — novel drugs only, excluding generics and label supplements.
MORTON GROVE's Therapeutic Areas
MORTON GROVE's approved drugs and pipeline span 2 therapeutic areas, led by Gastroenterology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
MORTON GROVE's Top Competitors
MORTON GROVE's closest competitors by therapeutic-area and drug-target overlap include BAUSCH, Takeda, and APOTHECON. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
MORTON GROVE Pipeline Snapshot
Active clinical trials for MORTON GROVE across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Gastroenterology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1989-05-25
- Latest
- 1996-03-01
- Applications
- 22